Ogilvie Jennifer B, Piatigorsky Eli J, Clark Orlo H
Division of Surgical Oncology, Section of Endocrine Surgery, University of Pittsburgh Medical Center, 497 Scaife Hall, Pittsburgh, PA 15261-1497, USA.
Adv Surg. 2006;40:223-38. doi: 10.1016/j.yasu.2006.06.003.
When not to perform fine needle aspiration of a thyroid nodule In summary, FNA of thyroid nodules has become one of the most useful, safe, and accurate tools in the diagnosis of thyroid pathology. Thyroid nodules that should be considered for FNA include any firm, palpable, solitary nodule or nodule associated with worrisome clinical features (rapid growth, attachment to adjacent tissues, new hoarseness, or palpable lymphadenopathy). FNA should also be performed on nodules with suspicious ultrasonographic features (microcalcifications, rounded shape, predominantly solid composition); dominant or atypical nodules in multinodular goiter; complex or recurrent cystic nodules; or any nodule associated with palpable or ultrasonographically abnormal cervical lymph nodes. Finally, FNA should be performed on any abnormal-appearing or palpable cervical lymph nodes. The management of thyroid nodules based on FNA findings is summarized in Table 2. It can be argued that in certain circumstances the results of thyroid FNA do not change the surgical management of a thyroid nodule, and thus preoperative FNA may be unnecessary. These cases include solitary nodules in patients who have a strong family history of thyroid cancer, multiple endocrine neoplasia type II, or radiation to the head and neck. These patients when they have thyroid nodules have at least a 40% risk for thyroid cancer and frequent multifocal or bilateral disease and should undergo total thyroidectomy with or without central neck lymph node dissection. Patients who have multinodular goiter and compressive symptoms, patients who have Graves disease and a thyroid nodule, or patients who have large (greater than 4 cm) or symptomatic unilateral thyroid nodules could also be considered for total thyroidectomy or lobectomy as indicated without preoperative FNA. Finally, patients who have a solitary hyperfunctioning nodule on radioiodine scan and a suppressed TSH have an extremely low incidence of malignancy and may be considered for therapeutic thyroid lobectomy or radioiodine ablation as indicated without undergoing FNA biopsy.
何时不应进行甲状腺结节的细针穿刺活检 总之,甲状腺结节的细针穿刺活检已成为诊断甲状腺病变最有用、最安全且最准确的工具之一。应考虑进行细针穿刺活检的甲状腺结节包括任何质地硬、可触及的孤立结节或伴有令人担忧的临床特征(快速生长、与相邻组织粘连、新发声音嘶哑或可触及的淋巴结病)的结节。对于具有可疑超声特征(微钙化、圆形、主要为实性成分)的结节、多结节性甲状腺肿中的优势或非典型结节、复杂或复发性囊性结节,或任何与可触及的或超声检查异常的颈部淋巴结相关的结节,也应进行细针穿刺活检。最后,对于任何外观异常或可触及的颈部淋巴结,都应进行细针穿刺活检。基于细针穿刺活检结果的甲状腺结节管理总结于表2。可以认为,在某些情况下,甲状腺细针穿刺活检的结果不会改变甲状腺结节的手术管理方式,因此术前细针穿刺活检可能没有必要。这些情况包括有甲状腺癌、多发性内分泌腺瘤2型或头颈部放疗家族史的患者中的孤立结节。这些患者出现甲状腺结节时,患甲状腺癌的风险至少为40%,且常为多灶性或双侧性疾病,应接受全甲状腺切除术,可选择或不选择中央区颈部淋巴结清扫。有多结节性甲状腺肿且有压迫症状的患者、患有格雷夫斯病且有甲状腺结节的患者,或有大(大于4cm)的或有症状的单侧甲状腺结节的患者,也可根据需要考虑进行全甲状腺切除术或叶切除术,而无需术前细针穿刺活检。最后,放射性碘扫描显示有孤立性高功能结节且促甲状腺激素被抑制的患者,恶性肿瘤发生率极低,可根据需要考虑进行治疗性甲状腺叶切除术或放射性碘消融,而无需进行细针穿刺活检。